# AstronauTx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/astronautx

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.astronautx.bio
- Total disclosed funding: $62M
- Latest round: Series A (Oct 9, 2023)
- Investors on record: 8

## About

Established in 2019 and based in London, UK, AstronauTx Ltd operates as a biotechnology company that develops drugs that target astrocytes, a type of brain cell, to treat dementia. In October 2023, AstronauTx Limited raised GBP 48 million in series A funding led by Novartis Venture Fund, with participation from MPM Capital, Brandon Capital, EQT Life Sciences, Bristol Myers Squibb, and SV Health Investors.

AstronauTx is a biotechnology business that is working on novel therapeutics for neurodegenerative illnesses such as Alzheimer's disease, Ataxia, Huntington's disease, Parkinson's disease, Motor neuron disease, and Dementia. The company's strategy is to attack the fundamental causes of these disorders, such as toxic protein buildup and disruption of normal brain function. Additionally, the firm has a portfolio of small-molecule therapies targeted to increase toxic protein clearance from the brain, promote metabolism for efficient network operation, and provide trophic support for long-term neuronal health.

The company plans to use the October 2023 funding to grow its product offerings and follow through with the development of a molecular novel drug in clinical trials.

## Funding rounds

- Series A, Oct 9, 2023, $59M — Novartis Venture Fund, EQT Life Sciences, SV Health Investors, Brandon Capital Partners, MPM BioImpact, Bristol-Myers Squibb Company
- Seed, Apr 15, 2020, $3.6M — UCL Technology Fund, UK Future Fund

## Investors

- UCL Technology Fund (https://capitalatlas.ai/funds/ucl-technology-fund) — Seed
- UK Future Fund — Seed
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A
- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- Bristol-Myers Squibb Company — Series A